Header Logo

Connection

Roumen Balabanov to Magnetic Resonance Imaging

Back to Details
This is a "connection" page, showing publications Roumen Balabanov has written about Magnetic Resonance Imaging.
Roumen Balabanov
Connection Strength
0.059
Magnetic Resonance Imaging
  1. Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study. Adv Ther. 2021 07; 38(7):3724-3742.
    View in: PubMed
    Score: 0.031
  2. Treatment of natalizumab-associated PML with filgrastim. Ann Clin Transl Neurol. 2019 May; 6(5):923-931.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.